Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Taking A Look At Eli Lilly's Q3 2024 Revenue Miss Amid Supply Chain Challenges
02:15pm, Wednesday, 30'th Oct 2024
Eli Lilly had $11.4 billion in revenue for the quarter (up 20% versus Q3 figures from last year), with a net income of $970 million after expenses. Analysts at the various Wall Street firms expected L
Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
12:50pm, Wednesday, 30'th Oct 2024
Eli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates.
Eli Lilly: The Stock Might Have Peaked
12:01pm, Wednesday, 30'th Oct 2024
Eli Lilly and Company reported third quarter results and missed expectations and had to lower its guidance, which was a huge disappointment for investors. But in the last few years, Eli Lilly was a gr
Why Eli Lilly Stock Is Sinking Today
11:34am, Wednesday, 30'th Oct 2024
The big pharmaceutical company provided a disappointing Q3 update.
Lilly (LLY) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:35am, Wednesday, 30'th Oct 2024
While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare
RDDT's Big Rally, LLY Plunges on Mounjaro & Zepbound Sales Miss
10:14am, Wednesday, 30'th Oct 2024
The morning's biggest winner is Reddit (RDDT) after the social media platform turned a profit and reported higher-than-expected guidance. Eli Lilly (LLY) reported an "uncharacteristic" miss despite Mo
SMCI, LLY Will Make "Very Difficult" Day to Break Resistance
10:10am, Wednesday, 30'th Oct 2024
Supermicro's (SMCI) continued accounting woes and Eli Lilly's (LLY) sharp plummet do no favors for the technology and health care sectors. These names are just two factors that Kevin Green believes wi
Lilly Lowers Forecast on Weight-Loss Disappointment
10:08am, Wednesday, 30'th Oct 2024
Eli Lilly & Co. lowered guidance on lackluster sales of its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro. Madison Muller reports on "Bloomberg Open Interest.
Eli Lilly Stock Dives Toward Worst Day Since 2000 On Disappointing Earnings, Zepbound Sales
09:45am, Wednesday, 30'th Oct 2024
Drug maker Eli Lilly's share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare misst
Eli Lilly tumbles as weight loss drug sales underwhelm, guidance slashed
09:39am, Wednesday, 30'th Oct 2024
Eli Lilly and Co (NYSE:LLY) shares fell over 12% on Wednesday after the drug maker slashed guidance for the year following underwhelming figures for the third quarter. Sales of Eli's blockbuster weigh
Eli Lilly (LLY) Lags Q3 Earnings and Revenue Estimates
08:56am, Wednesday, 30'th Oct 2024
Eli Lilly (LLY) came out with quarterly earnings of $1.18 per share, missing the Zacks Consensus Estimate of $1.52 per share. This compares to earnings of $0.10 per share a year ago.
Eli Lilly's stock tumbles as Mounjaro, Zepbound sales miss by wide margins
08:35am, Wednesday, 30'th Oct 2024
Eli Lilly's stock heads for biggest selloff since 2008 after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
Eli Lilly Stock Tumbles as Q3 Sales, Profits Fall Well Short of Estimates
07:25am, Wednesday, 30'th Oct 2024
Eli Lilly (LLY) shares tumbled 10% after its third-quarter results fell well short of analysts' estimates before the bell Wednesday.
Eli Lilly Dives On Earnings Miss As Diabetes, Weight-Loss Drugs Fall Short
07:00am, Wednesday, 30'th Oct 2024
Eli Lilly earnings and revenue missed Q3 views, with sales light for its diabetes and weight-loss drugs. Eli Lilly stock dived Wednesday.
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
06:57am, Wednesday, 30'th Oct 2024
Eli Lilly reported third-quarter adjusted profit and revenue that missed expectations, sending its stock tumbling roughly 10% Skyrocketing demand for injectable weight loss and diabetes drugs has forc
